Towards a cell therapy for Parkinsons disease: Fully integrated closed system expansion and differentiation of pluripotent stem cells to mesencephalic dopaminergic progenitor cells
integrated GMP cell processing platform, CliniMACS Prodigy®, we previously developed a cultivation and expansion workflow for PSCs. Now we have adapted the lab protocol for the differentiation to mesDA progenitor…

